This Israeli Biotech Firm Is Trying To Print Organs For Transplants

Published: Jun 14, 2017

Israeli biotech firm CollPlant is trying to patent a technology that that could eventually lead to the three-dimensional printing of hearts, kidneys and other vital human tissues.

CollPlant, based in Ness Ziona, has filed a patent application in the United States for its “bio-ink” - made of a proprietary plant product that mimics the qualities of collagen, a protein responsible for the elasticity of human skin and other organs.

Back to news